Preparation and body distribution of freeze-dried powder of ursolic acid phospholipid nanoparticles

Drug Development and Industrial Pharmacy

Volumn 35, Issue 3, 2009, Pages 305-310

  Zhou, Xiao Ju ^a   Hu, Xian Ming ^a   Yi, Yi Mu ^b   Wan, Jing ^b  

^a WUHAN UNIVERSITY   (China)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Body distribution; Freeze dried powder; Phospholipid nanoparticles; Triterpenoid; Ursolic acid

Indexed keywords

NANOPARTICLE; PHOSPHOLIPID; POLOXAMER; URSOLIC ACID;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG LIVER LEVEL; EMULSION; EVAPORATION; FREEZE DRYING; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VITRO STUDY; MALE; MOUSE; NONHUMAN; PARTICLE SIZE; POWDER;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; AREA UNDER CURVE; BIOLOGICAL AVAILABILITY; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CRATAEGUS; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; FREEZE DRYING; INJECTIONS, INTRAVENOUS; LIVER; MALE; MICE; NANOPARTICLES; PHOSPHOLIPIDS; POLOXAMER; SOYBEANS; TISSUE DISTRIBUTION; TRITERPENES;

EID: 61649111175     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.1080/03639040802302165     Document Type: Article

References (37)

1. Abdelwahed, W., Degobert, G., & Fessi, H. (2006a). Investigation of nanocapsules stabilization by amorphous excipients during freeze-drying and storage. Eur. J. Pharm. Biopharm., 63, 87-94.
2. Abdelwahed, W., Degobert, G., & Fessi, H. (2006b). A pilot study of freeze-drying of poly(epsilon-caprolactone) nanocapsules stabilized by poly(vinyl alcohol): Formulation and process optimization. Int. J. Pharm., 17, 178-188.
3. Brigger, I., Dubernet, C., & Couvreur, P. (2002). Nanoparticles in cancer therapy and diagnosis. Adv. Drug Deliv. Rev., 54, 631-651.
4. Cardenas, C., Quesada, A. R., & Medina, M. A. (2004). Effects of ursolic acid on different steps of the angiogenic process. Biochem. Biophys. Res. Commun., 320, 402-40.
5. Chacon, M., Molpeceres, J., Berges, L., Guzman, M., & Aberturas, M. R. (1999). Stability and freeze-drying of cyclosporine loaded poly(D,L lactide-glycolide) carriers. Eur. J. Pharm. Sci., 8, 99-107.
6. Couvreur, P., Dubernet, C., & Puisieux, F. (1995). Controlled drug delivery with nanoparticles: Current possibilities and future trend. Eur. J. Pharm. Biopharm., 41, 2-13.
7. Desai, M. P., Labhasetwar, V., Amidon, G. L., & Levy, R. J. (1996). Gastrointestinal uptake of biodegradable microparticles: Effect of particle size. Pharm. Res., 13, 1838-1845.
8. Fessi, H., Devissaguet, J. P., & Puisieux, F. (1992). Process for the preparation of dispersible colloidal systems of a substance in the form of nanoparticles, US Patent No. 5, 118, 528.
9. Fumiyoshi, I., & Tomoko, N. (2005). Preparation and characterization of solid lipid nanoparticles loaded traditional Chinese medicine. Colloids Surf. B Biointerfaces, 41, 257-262.
10. Goldblith, S. A., Rey, L., & Rothmayr, W. W. (1975). Freeze drying and advanced food technology. London, UK: Academic press.
11. Gupta, P. K., & Hung, C. T. (1989). Quantitative evaluation of targeted drug delivery system. Int. J. Pharm., 56(3), 217-226.
12. Hsu, Y. L., Kuo, P. L., & Lin, C. C. (2004). Proliferative inhibition, cell cycle dysregulation, and induction of apoptosis is by ursolic acid in human non-small cell lung cancer A549 cells. Life Sci., 75, 2303-2316.
13. Huang, M. T., Ho, C. T., Wang, Z. Y., Ferraro, T., Lou, Y. R., Stauber, K., Ma, W., Georgiadis, C., Laskin, J. D., & Conney, A. H. (1994). Inhibition of skin tumorigenesis by rosemary and its constituents camosol and ursolic acid. Cancer Res., 54, 701-708.
14. Hutchings, A., Scott, A. H., Lewis, G., & Cunningham, A. (1996). Zulu medicinal plants: An inventory. Scotsville: University of Natal Press.
15. Kim, K. A., Lee, J. S., Park, H. J., Kim, J. W., Kim, C. J., Shim, I. S., Kim, N. J., & Lim, S. (2004). Inhibition of cytochrome P450 activities by oleanolic acid and ursolic acid in human liver microsomes. Life Sci., 74, 2769-2779.
16. Konan, Y. N., Gurny, R., & Allémann, E. (2002). Preparation and characterization of sterile and freeze-dried sub-200 nm nanoparticles. Int. J. Pharm., 233, 239-252.
17. Lee, H. Y., Chung, H. Y., Kim, K. H., Lee, J. J., & Kim, K. W. (1994). Induction of differentiation in the cultured F9 teratocarcinoma stem cells by triterpene acids. J. Cancer Res. Clin. Oncol., 120(9), 513-518.
18. Liu, J. (1995). Pharmacology of oleanolic acid and ursolic acid. J. Ethnopharmacol., 49, 4957-4968.
19. Martin-Aragon, S., de las Heras, B., Sanchez-Reus, M. I., & Benedi, J. (2001). Pharmacological modification of endogenous antioxidant enzymes by ursolic acid on tetrachloride-induced liver damage in rats and primary cultures of rat hepatocytes. Exp. Toxicol. Pathol., 53, 199-206.
20. Mehnert, W., & Mader, K. (2001). Solid lipid nanoparticles production, characterization and applications. Adv. Drug Deliv. Rev., 47, 165-196.
21. Moghimi, S. M. (1995). Mechanisms regulating body distribution of nanospheres conditioned with pluronic and tetronic block co-polymers. Adv. Drug Deliv. Rev., 16, 183-193.
22. Niikawa, M., Hayashi, H., Sato, T., Nagase, H., & Kito, H. (1993). Isolation of substances from glossy privet (Ligustrum lucidum Ait.) inhibiting the mutagenicity of benzo[a]pyrene in bacteria. Mutat. Res., 319, 1-9.
23. Panyam, J., & Labhasetwar, V. (2003). Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv. Drug Deliv. Rev., 55(3), 329-347.
24. Perez-Camino, M. C., & Cert, A. (1999). Quantitative determination of hydroxy pentacyclic triterpene acids in vegetable oils. J. Agric. Food Chem., 47, 1558-1572.
25. Price, K. R., Johnson, I. T., & Fenwick, R. R. (1987). The chemistry and biological significance of saponins in foods and feeding staffs. CRC Crit. Rev. Food Sci. Nutr., 26, 27-135.
26. Saraswat, B., Visen, P. K. S., & Dayal, R. (1996). Protective action of ursolic acid against chemical induce hepatotoxicity in rats. Indian J. Pharmacol., 28, 232-239.
27. Schubert, M. A., & Muller-Goymann, C. C. (2003). Solvent injection as a new approach for manufacturing lipid nanoparticles - evaluation of the method and process parameters. Eur. J. Pharm. Biopharm., 55, 125-131.
28. Siekmann, B., & Westesen, K. (1996). Investigation on solid lipid nanoparticles prepared by precipitation in o/w emulsion. Eur. J. Pharm. Biopharm., 43, 104-109.
29. Simon, A., Najid, A., Chulia, A. J., Delage, C., & Rigaud, M. (1992). Inhibition of lipoxygenase activity and HL60 leukemic cell proliferation by ursolic acid isolated from heather flowers (Calluna vulgaris). Biochim. Biophys. Acta, 1125, 68-72.
30. Sjöström, B., & Bergenstahl, B. (1992). Preparation of submicron drug particles in lecithin-stabilized o/w emulsions I. Model studies of the precipitation of cholestreryl acetate. Int. J. Pharm., 88, 53-62.
31. Trotta, M., Gallarate, M., Pattarino, F., & Morel, S. (2001). Emulsions containing partially water-miscible solvents for the preparation of drug nanosuspensions. J. Control. Release, 76, 119-128.
32. Wang, C. H., & Sun, D. J. (1998). Advance in the study of physical and chemical stability of liposomes. Chin. Pharm. J., 3365-3368.
33. Xiong, X. J., Chen, W., & Li, K. Q. (2001). Study on the experiment of the poison of ursolic acid. J. Yichun Medi. Coll., 13, 54.
34. Yang, S. C., Lu, L. F., Cai, Y., Zhu, J. B., Liang, B. W., & Yang, C. Z. (1999). Body distribution in mice of intravenously injected camptothec in solid lipid nanoparticles. J. Control. Release, 59, 299-307.
35. You, H. J., Choi, C. Y., Kim, J. Y., Park, S. J., Hahm, K. S., & Jeong, H. G. (2001). Ursolic acid enhances nitric oxide and tumor necrosis factor-α production via nuclear factor-kB activation in the resting macrophages. FEBS Lett., 509, 156-160.
36. Young, H. S., Chung, H. Y., Lee, C. K., Park, K. Y., Yokosawa, T., & Oura, H. (1994). Ursolic acid inhibits aflatoxin B1-induced mutagenisity in a salmonella assay system. Biol. Pharm. Bull., 17, 990-992.
37. Zhou, X. J., & Yi, Y. M. (2004). Preparation and quality evaluation of ursolic acid phospholipid nanoparticles. Herald Med., 23(7), 492-494.